《全日總結》恆指升257點 教育股急漲 新東方升13%
輝瑞藥廠指「復必泰」有效應對新冠變種Omicron,道指升35點或0.1%,內地股市上升,港股在科技股帶動下造好。恆指高開171點,其後升幅曾擴大至327點見24,324點,全日升257點或1.08%,收24,254點;國指升134點或1.56%,收8,657點;恆生科技指數升132點或2.23%,收6,103點。大市全日成交總額1,251.81億元,滬、深港通南下交易分別淨流入15.95億及16.14億元人民幣。
科技股方面,阿裏巴巴(09988.HK)成立子公司加碼佈局元宇宙,股價升2.3%報123.4元。騰訊(00700.HK)升1.2%報472.6元,美團(03690.HK)外賣應用程式故障,股價升幅收窄至0.7%報247元。小米(01810.HK)據報斥15億人幣在滬成立集成電路芯片設計公司,小米升0.9%報19.4元。京東(09618.HK)升1.3%報311元。網易(09999.HK)則跌0.4%。
據報快手(01024.HK)準備裁員最多30%,快手低開後倒升1.8%報85.75元。萬國數據(09698.HK)夥深圳燃氣及三環集團達成清潔能源技術戰略合作,股價抽升7.7%。網絡醫健股阿裏健康(00241.HK)及京東健康(06618.HK)各升6.4%及6%,網絡保險股衆安在線(06060.HK)亦升5.5%。手機相關股方面,瑞聲(02018.HK)遭摩通下調目標價,股價仍升1.7%。舜宇(02382.HK)升3.7%。電訊設備股中興(00763.HK)抽升7.6%。
輝瑞指「復必泰」有效應對新冠變種Omicron,復星醫藥(02196.HK)升6%,生物科技股信達生物(01801.HK)及中生製藥(01177.HK)各升3.4%及4.3%。石藥(01093.HK)炒高6.1%。電子煙概念股方面,比亞迪電子(00285.HK)升4.1%。華寶國際(00336.HK)折讓11.9%配股淨籌21.6億元上板,股價跌8.6%報18.56元。
發改委提出傢俱家裝下鄉補貼和新一輪汽車下鄉,創維(00751.HK)升18.6%報5.87元,海爾智家(06690.HK)及國美(00493.HK)各升5.6%及7.5%。汽車股吉利(00175.HK)及廣汽(02238.HK)各升3.2%及4.1%。其餘內需股見支持,海底撈(06862.HK)及恆安(01044.HK)各升3.6%及3.8%,蒙牛(02319.HK)、百威亞太(01876.HK)及潤啤(00291.HK)各逾2%。「中國巴菲特」段永平以沽出認沽期權投資新東方(09901.HK),新東方抽升13.2%。思考樂(01769.HK)升31.2%,新東方在線(01797.HK)及希望教育(01765.HK)各升14.3%及10.5%。
據報銀娛及澳博維持營運中介人貴賓廳,金沙續自營貴賓廳,濠賭股銀娛(00027.HK)及澳博(00880.HK)各跌0.2%及1.3%,金沙中國(01928.HK)則升2.8%。內房股見反彈,龍湖(00960.HK)、碧桂園(02007.HK)及萬科(02202.HK)各升2.9%至3.5%,融創(01918.HK)升5.1%。恆大(03333.HK)及恆大物業(06666.HK)各升4%及3.5%。內地物管股碧桂園服務(06098.HK)升4.5%。
其他藍籌股方面,匯控(00005.HK)跌0.4%報45.3元,港交所(00388.HK)平收報471.2元,友邦(01299.HK)跌0.4%報82.9元。招行(03968.HK)升2.4%報66.5元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.